The Food and Drug Administration announced that Philips recalled the software following 109 reported injuries and two ...
The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...
Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...
1d
The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3% ...
Request To Download Free Sample of This Strategic Report @ The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global ECG ...
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...
An audit of the Electricity Company of Ghana rsquo;s (ECG) revenue collection has uncovered GH?490 million discrepancy in ...
Several companies started designing implantable diagnostic devices for syncope and general cardiac arrhythmia monitoring, [9–12] demonstrating a growing interest about this application not only ...
Symptoms such as heart pain, palpitations and shortness of breath may be transient and can be difficult to record by conventional devices. With the OMRON® Portable ECG Monitor HCG-801 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback